CTOs on the Move

Vertex Pharmaceuticals

www.vrtx.com

 
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.vrtx.com
  • 50 Northern Avenue
    Boston, MA USA 02210
  • Phone: 617.341.6100

Executives

Name Title Contact Details
E. Atkinson
Executive Vice President and Chief Technical Operations Officer Profile
Michael Kennedy
Director, Cyber Security Profile
Michael Daly
Vice President & Chief Information Security Officer Profile
Tom Philbin
Senior Director, Head of Enterprise Architecture Profile
Stephen Schoepke
Associate Director, Information Security/Sr. Privacy Engineer Profile

Similar Companies

Ionpath

Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpath`s MIBI™ (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis.

VitroLabs

We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good.

Antibody Solutions

Antibody Solutions is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

South Pacific Bio Medical

South Pacific Bio Medical is a Temecula, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gradalis

Gradalis, Inc. is a fully integrated biotechnology company based in Dallas, Texas that focuses on the development, manufacturing, and commercialization of drugs, vaccines, tools, and diagnostics primarily in the area of cancer. Gradalis has its own GMP manufacturing facility along with highly skilled technical leadership and staff and a strategic partnership with Mary Crowley Cancer Research Centers for clinical development of Gradalis products. The Company has two primary platforms, one centered on personalized autologous vaccines and a second focused on bifunctional short hairpin RNA (shRNA) to enable specific protein knockdown. In addition. Gradalis has numerous partnerships and joint ventures that provide it with access to other cutting edge clinical and pre-clinical stage programs.